Retinol binding protein 4 primes the NLRP3 inflammasome by signaling through Toll-like receptors 2 and 4.

Proceedings of the National Academy of Sciences of the United States of America
Pedro M Moraes-VieiraB B Kahn

Abstract

Adipose tissue (AT) inflammation contributes to systemic insulin resistance. In obesity and type 2 diabetes (T2D), retinol binding protein 4 (RBP4), the major retinol carrier in serum, is elevated in AT and has proinflammatory effects which are mediated partially through Toll-like receptor 4 (TLR4). We now show that RBP4 primes the NLRP3 inflammasome for interleukin-1β (IL1β) release, in a glucose-dependent manner, through the TLR4/MD2 receptor complex and TLR2. This impairs insulin signaling in adipocytes. IL1β is elevated in perigonadal white AT (PGWAT) of chow-fed RBP4-overexpressing mice and in serum and PGWAT of high-fat diet-fed RBP4-overexpressing mice vs. wild-type mice. Holo- or apo-RBP4 injection in wild-type mice causes insulin resistance and elevates PGWAT inflammatory markers, including IL1β. TLR4 inhibition in RBP4-overexpressing mice reduces PGWAT inflammation, including IL1β levels and improves insulin sensitivity. Thus, the proinflammatory effects of RBP4 require NLRP3-inflammasome priming. These studies may provide approaches to reduce AT inflammation and insulin resistance in obesity and diabetes.

References

Apr 10, 1999·The Journal of Biological Chemistry·J C ChowF Gusovsky
Dec 15, 2004·Microbes and Infection·Katherine A FitzgeraldDouglas T Golenbock
Oct 21, 2006·The Journal of Clinical Investigation·Hang ShiJeffrey S Flier
Jun 28, 2007·The Journal of Clinical Endocrinology and Metabolism·Aiwei Yao-BorengasserPhilip A Kern
Sep 20, 2007·The Journal of Clinical Endocrinology and Metabolism·Qibin QiXu Lin
May 23, 2008·Diabetologia·M van HoekE J G Sijbrands
Nov 4, 2008·Clinica Chimica Acta; International Journal of Clinical Chemistry·Ji-Won LeeDuk-Chul Lee
Oct 21, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ryan W Himes, C Wayne Smith
Oct 24, 2009·Obesity·Lkhagvasuren MunkhtulgaSadahiko Iwamoto
Oct 5, 2010·Trends in Endocrinology and Metabolism : TEM·A Christine Könner, Jens C Brüning
Jan 11, 2011·Nature Medicine·Bolormaa VandanmagsarVishwa Deep Dixit
Jan 10, 2012·Cell Metabolism·Rinke StienstraMihai G Netea
Feb 3, 2012·Cold Spring Harbor Perspectives in Biology·Kim Newton, Vishva M Dixit
Apr 14, 2012·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·P M M Moraes-VieiraN O S Câmara
Jul 28, 2012·Clinical Rheumatology·Francesco UrsiniRosa Daniela Grembiale
Sep 18, 2013·Diabetes, Obesity & Metabolism·A W Ferrante
Nov 26, 2013·European Journal of Immunology·Pedro M M Moraes-VieiraNiels O S Câmara
Dec 3, 2013·The Journal of Clinical Investigation·Anthony W Ferrante
Mar 27, 2015·BioFactors·Jagannathan RamAmbady Ramachandran
Jun 30, 2015·Cell Reports·Jong-Seok MoonAugustine M K Choi
Jun 30, 2015·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Gautam Kumar PandeyKuppan Gokulakrishnan
Jan 19, 2016·Frontiers in Immunology·Angela CastoldiPedro M Moraes-Vieira
Oct 22, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Seung-Ah LeeWilliam S Blaner
Oct 5, 2016·Cold Spring Harbor Perspectives in Biology·Gökhan S Hotamisligil, Roger J Davis
Oct 26, 2016·Nature Communications·Min XieDaolin Tang
Nov 1, 2016·Diabetes·Spencer J ThompsonTimothy E Graham
Aug 22, 2018·The Journal of Biological Chemistry·Ronja FeddersMichael Schupp
Feb 1, 2019·Pharmacology & Therapeutics·William S Blaner
Feb 2, 2019·The Lancet. Diabetes & Endocrinology·Lindsay M JaacksMajid Ezzati
May 16, 2019·Journal of Leukocyte Biology·Lauar MonteiroPedro Manoel M Moraes-Vieira

❮ Previous
Next ❯

Citations

Apr 2, 2021·Frontiers in Physiology·Julia S SteinhoffMichael Schupp
May 7, 2021·Molecular and Cellular Endocrinology·Pamela A Nono Nankam, Matthias Blüher

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Asprosin

Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.